share_log

ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | SC 13D: Statement of acquisition of beneficial ownership by individuals-Eureka Therapeutics, Inc.(71.8%)

SEC announcement ·  Oct 27, 2023 19:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more